Latest Leadership News

Aura Energy announces the immediate resignation of Managing Director Andrew Grove, with Executive Chair Philip Mitchell stepping in to manage operations during critical funding talks. The company remains focused on advancing its uranium and polymetallic projects in Mauritania and Sweden.

Infratil Limited is expanding its footprint in New Zealand's energy sector by acquiring an additional 4.92% stake in Contact Energy for NZ$437.7 million, combining debt and equity financing.

PWR Holdings has announced significant board changes following its AGM, with founder Kees Weel stepping down as Managing Director to become Chairman, alongside new appointments to key governance roles.

PWR Holdings announces a pivotal leadership transition alongside the completion of its new global headquarters, reporting a transitional FY25 with mixed financial results but a confident outlook for FY26.

Prominence Energy has achieved a pivotal milestone with the award of Petroleum Exploration Licence 803 for its Gawler Hydrogen Project, positioning itself as a key player in Australia's emerging natural hydrogen sector. The company also strengthened its leadership team and completed a $1.75 million capital raise to fund its growth ambitions.

De.mem Limited has acquired Core Chemicals Ltd for approximately $3 million, significantly expanding its footprint in the Australian gold mining sector and enhancing its pro-forma EBITDA to $1.6 million.

Hawk Resources has raised A$5 million and secured an option to earn up to 80% of the Olympus Scandium Project in Western Australia, aiming to advance exploration of a large-scale scandium anomaly in a Tier-1 jurisdiction.

Avenira Limited has appointed John He as Executive Chairman and CEO, marking a significant leadership reshuffle aimed at advancing the Wonarah Phosphate Project and strengthening strategic partnerships.

Archer Materials has entered a strategic collaboration with Emergence Quantum to fast-track the development of graphene-based quantum devices, aiming to bridge cutting-edge science with commercial applications.

Orthocell has raised $30 million through an institutional placement to accelerate the US commercialisation of its flagship nerve repair product Remplir and expand its regenerative medicine portfolio.

Coventry Group reports a 4.5% increase in Q1 FY26 sales alongside a notable EBITDA turnaround, underpinned by a $10 million cost-out program and fresh executive appointments.

AVITA Medical has appointed Board Chairman Cary Vance as Interim CEO following Jim Corbett's departure, while preliminary third-quarter revenue is expected to reach approximately $17 million.